Spinal Cord Injury and Stem Cell-Based Trials: What's the Latest?

In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based research for treatment of spinal cord injury. Asterias has a $14 million CIRM grant to support their embryonic stem cell-based clinical trial for spinal cord injury. Kevin McCormack, CIRM's Director of Public Communications, moderated the conversation.